Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Viemed Healthcare Inc VMD

Viemed Healthcare, Inc. through its subsidiaries, is a provider of home medical equipment (HME) and post-acute respiratory healthcare services in the United States. The Company’s service offerings are focused on effective in-home treatment with clinical practitioners providing therapy and counselling to patients in their homes using cutting edge technologies. The Company’s products and services include Home Medical Equipment, In-home sleep testing, and Healthcare staffing. Home Medical Equipment provides respiratory and other home medical equipment, including home ventilation, bi-level positive airway pressure (BiPAP) and continuous positive airway pressure (CPAP) devices, percussion vests, and other medical equipment. In-home sleep testing provides in home sleep apnea testing services. Healthcare staffing provides healthcare staffing and recruitment services. The Company provides home medical equipment services through its interest in East Alabama HomeMed, LLC (HomeMed).


NDAQ:VMD - Post by User

Comment by donmayneon Jan 20, 2022 8:34pm
137 Views
Post# 34340655

RE:RE:RE:RE:stock options

RE:RE:RE:RE:stock optionsThe 2022 stock incentive awards were just filed. There is some difference from prior years.  The total number of options were down. The exercise price is in US dollars ($5.21).  However, they granted RSUs vesting over 3 years (subect to some undisclosed contingency) where the company gives a right to common shares on each anniversary date.  So there could be some selling
They also granted some Phantom Shares (subject to continuing employment) where the company pays out the value of the shares on the vesting dates.

Todays award will reduce the profit line of the company. The RSUs and Phantom shares will be $1.875 million at a $5 US share price.  


  Date of Grant Options granted Exercise Price Expiry date 1/3 Vesting
Options 18-Jan-22                371,102 5.21 US 18-Jan-32 Yr 1, Yr 2, Yr 3
Restricted Stock Unit 18-Jan-22                252,345 - 18-Jan-25 Yr 1, Yr 2, Yr 3
Phantom Shares 18-Jan-22                123,692 - 18-Jan-25 Yr 1, Yr 2, Yr 3
1. Options granted to reporting person on January 18, 2022, which vest in three equal annual installments beginning on the first anniversary of the grant date.
2. Each Restricted Stock Unit (RSU) represents a contingent right to receive one common share.  
3. Restricted Stock Units granted to reporting person on January 18, 2022, which vest in three equal installments beginning on the first anniversary of the grant date.
4. Each share of phantom stock represents a right to receive the cash value of one share of the Issuer's common shares which will be determined based on the Issuer's share price on the vesting date.
5. Represents an award granted in 2022 under the Issuer's Phantom Share Unit Plan which vests in equal installments on January 18, 2023, January 18, 2024, and January 18, 2025, subject to the Reporting Person's continued employment with the Issuer on such vesting date.
   

<< Previous
Bullboard Posts
Next >>